Enliven Therapeutics, Inc.
ELVN
31 insider filings · Latest: Aug 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Oct 15 8:38 PM | Heyman Richard A. | Proposed Sale | 1,270 | $27.75 | $35.2K | — | View → |
| Oct 9, 2024 | Oct 9 8:27 PM | Lyssikatos Joseph P | Proposed Sale | 12,000 | $28.01 | $336.1K | — | View → |
| Oct 9, 2024 | Oct 9 8:16 PM | Kintz Samuel | Proposed Sale | 12,000 | $28.01 | $336.1K | — | View → |
| Oct 8, 2024 | Oct 8 7:59 PM | Ballal Rahul D. | Proposed Sale | 10,420 | $27.45 | $286.0K | — | View → |
| Oct 4, 2024 | Oct 4 8:28 PM | Heyman Richard A. | Proposed Sale | 2,540 | $25.51 | $64.8K | — | View → |
| Oct 1, 2024 | Oct 1 8:14 PM | Hohl Benjamin | Proposed Sale | 12,009 | $25.54 | $306.7K | — | View → |
| Sep 30, 2024 | Sep 30 8:19 PM | Hohl Benjamin | Proposed Sale | 491 | $24.13 | $11.8K | — | View → |
| Apr 28, 2025 | — | Hohl Benjamin | Proposed Sale | 3,250 | $18.21 | $59.2K | — | View → |
← Previous
Page 7 of 7
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 18 12:52 AM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Grant/Award | 112,500 | $27.16 | 112,500(D) | View → |
| Feb 12, 2026 | Feb 18 12:49 AM | Benjamin HohlCHIEF FINANCIAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:47 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
← Previous
Page 2 of 2